Netherlands-based LabPON has deployed Royal Philips’ IntelliSite Pathology Solution, becoming the world’s such first laboratory to transition completely towards digital diagnosis.

The solution will be used by the laboratory to assess and diagnose all clinical histology cases instead of with a microscope, improving laboratory efficiency, quality and service levels.

Philips Digital Pathology Solutions general manager Russell Granzow said: "Digitisation of pathology offers a new way to tackle some of the growing challenges in the field, like higher cancer rates and the massive quantity of slides generated annually at these sites."

"Digitisation of pathology offers a new way to tackle some of the growing challenges in the field."

LabPON pathologist Alexi Baidoshvili said: "Transitioning our entire workflow to digital processes demonstrates our commitment to ensuring our patients and clinical colleagues receive the fastest, most effective and best informed diagnoses possible."

Pathology plays a critical role in disease detection, specifically with cancer diagnosis. Digital pathology will offer new ways to extract more information from tissue samples and connect with other diagnostic modalities.

Philips IntelliSite Pathology Solution secured CE Mark approval for primary diagnostics in the European Union and Health Canada.

In the US, the solution obtained US Food Drug and Administration approval for diagnostic use in the evaluation of HER2 expression in breast cancer and is provided for research use.

LabPON is also partnering with two other labs in the country, including University Medical Center Groningen and Isala Klinieken in Zwolle, to establish a virtual network to share cases in a secure way and directly set up consultations.

Image: LabPON has deployed Philips IntelliSite Pathology Solution to assess and diagnose clinical histology cases. Photo: courtesy of Koninklijke Philips NV.